B.H.R. (Bruce) Wolffenbuttel
Lidmaatschap wetenschappelijke verenigingen:
- Nederlandsche Internisten Vereeniging (Dutch Assoc. for Internal Medicine, NIV)
- Nederlandse Vereniging Diabetes Onderzoek (Dutch Assoc. Diabetes Research, NVDO)
- Nederlandse Vereniging Endocrinologie (Dutch Society for Endocrinology, NVE)
- Endocrine Society
- European Society of Endocrinology
- American Diabetes Association (ADA)
- European Association for the Study of Diabetes (EASD)
- Diabetes UK (previously British Diabetes Association)
- European Society for Clinical Investigation (ESCI)
- American Society for Human Genetics (ASHG)
- Society for Inborn Errors of Metabolism (SSIEM)
- Royal Society of Medicine London
Previous member of
- Eerste Associatie Diabetes Verpleegkundigen (EADV)
- Diabetesvereniging Nederland (Dutch Diabetes Assoc., DVN)
- Dutch Atherosclerosis Society (DAS)
- European Atherosclerosis Society (EAS)
- Pituitary Society
Onderzoeksprojecten, gedetailleerd:
|
* The Durability of Twice-Daily Insulin Lispro Low Mixture Compared to Once-Daily Insulin Glargine when added to Existing Oral Therapy in Patients with Type 2 Diabetes and Inadequate Glycemic Control |
Eli Lilly |
|
* Fertility and obesity |
PhD supervisor |
|
* PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice |
Amgen |
|
* A Randomized Trial Comparing Combined Basal Insulin/Glargine and Exenatide Therapy (BET) with Combined Basal Insulin/Glargine and Bolus Insulin/ Humalog Lispro Therapy (BBT) in Subjects with Type 2 Diabetes, Being Treated by Glargine with Metformin Alone or with Combination of Metformin with Sulfonylurea |
Eli Lilly, now Amylin/BMS |
|
* The effects of obesity and weight reduction on inflammatory markers and site-specific adipocyte function in prediabetes |
PhD supervisor |
|
* Quality of life after treatment for pituitary adenoma and Cushing's disease |
PhD supervisor |
|
* Use of the RFFT cognitive function test in large-scale epidemiologic studies |
PhD supervisor |
|
* Growth hormone replacement therapy in childhood cancer survivors |
Novo Nordisk |
|
* Personalized risk assessment and therapeutical strategy to prevent and treat macrovascular disease in Type 2 diabetes |
PhD supervisor, Diabetes Research Foundation |
|
* Cognitive function in pituitary diseases |
PhD supervisor |
|
* Thyroid hormone disturbances in the LifeLines Cohort Study |
PhD supervisor |
|
* IEMO Thyroid trial in subjects 80+ |
PI for UMCG |
|
* GWA analysis for skin autofluorescence (together with AD Paterson, Toronto Canada & DCCT investigators) * Endocrine disruptors and their effect in the pathophysiology of obesity and type 2 diabetes |
|
|
* Metabolic syndrome & healthy obesity |
PhD supervisor |
|
* GWA analysis for T3T4 ratio in thyroid physiology |
|
|
* Type 2 diabetes and its treatment across Europe, analysis in the BioSHaRE-EU consortium |
PhD supervisor |
|
* Long-term Type 1 diabetes |
PI |
| Laatst gewijzigd: | 25 juni 2022 02:31 |